- Home
- DSGN vs USCB Comparison
DSGN vs USCB Comparison
Compare DSGN & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- USCB
- Stock Information
- Founded
- DSGN 2017
- USCB 2002
- Country
- DSGN United States
- USCB United States
- Employees
- DSGN N/A
- USCB N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- USCB Major Banks
- Sector
- DSGN Health Care
- USCB Finance
- Exchange
- DSGN Nasdaq
- USCB Nasdaq
- Market Cap
- DSGN 353.9M
- USCB 382.1M
- IPO Year
- DSGN 2021
- USCB 2021
- Fundamental
- Price
- DSGN $6.25
- USCB $17.11
- Analyst Decision
- DSGN Hold
- USCB Buy
- Analyst Count
- DSGN 3
- USCB 4
- Target Price
- DSGN $7.00
- USCB $16.13
- AVG Volume (30 Days)
- DSGN 208.4K
- USCB 30.8K
- Earning Date
- DSGN 11-07-2024
- USCB 01-23-2025
- Dividend Yield
- DSGN N/A
- USCB 1.17%
- EPS Growth
- DSGN N/A
- USCB 13.14
- EPS
- DSGN N/A
- USCB 1.04
- Revenue
- DSGN N/A
- USCB $71,791,000.00
- Revenue This Year
- DSGN N/A
- USCB N/A
- Revenue Next Year
- DSGN N/A
- USCB $15.26
- P/E Ratio
- DSGN N/A
- USCB $16.44
- Revenue Growth
- DSGN N/A
- USCB 10.04
- 52 Week Low
- DSGN $2.25
- USCB $10.25
- 52 Week High
- DSGN $7.77
- USCB $21.86
- Technical
- Relative Strength Index (RSI)
- DSGN 52.38
- USCB 33.91
- Support Level
- DSGN $5.55
- USCB $17.43
- Resistance Level
- DSGN $6.45
- USCB $19.61
- Average True Range (ATR)
- DSGN 0.56
- USCB 1.04
- MACD
- DSGN -0.04
- USCB -0.43
- Stochastic Oscillator
- DSGN 57.67
- USCB 14.04
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.